Product Information
PIROXICAM 20 MG CAPSULE is a generic product labeled by Micro Labs Limited, priced at $0.2147 per EA under NDC 42571017701. Its NADAC has been published 431 times since Jul 4, 2018.
FDA first approved this application on Dec 29, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Micro Labs LimitedNDC
42571017701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PIROXICAMApproval Type
Generic (ANDA)
FDA Application
ANDA206152FDA Approved
12/29/2017
TE Code
AB
On Market Since
3/1/2018
Pharmacological Classes
Price Statistics
The NADAC for PIROXICAM 20 MG CAPSULE has been published 431 times since Jul 4, 2018, and over the history we have for it it has declined 74.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2147 per EA |
|---|---|
| All-time high | $0.8498 (Jul 11, 2018) |
| All-time low | $0.1730 (Nov 20, 2024) |
| 52-week high | $0.2240 |
| 52-week low | $0.1779 |
| Median price | $0.3944 |
| Average price | $0.3843 |
| Largest weekly change | +53.6% (May 19, 2021) |
| Weeks tracked | 431 |
| Tracking since | Jul 4, 2018 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Piroxicam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PIROXICAM 20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PIROXICAM 20 MG CAPSULE, manufactured by Micro Labs Limited, is $0.2147 per EA (NDC 42571017701), effective Sep 30, 2026.
How has the price of PIROXICAM 20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PIROXICAM 20 MG CAPSULE has declined 74.7%. It has been tracked across 431 weekly CMS publications since Jul 4, 2018.
What are the highest and lowest recorded NADAC prices for PIROXICAM 20 MG CAPSULE?
Since Jul 4, 2018, the NADAC for PIROXICAM 20 MG CAPSULE has ranged from a low of $0.1730 (Nov 20, 2024) to a high of $0.8498 (Jul 11, 2018), with a median of $0.3944 per EA.
Are there cheaper alternatives to PIROXICAM 20 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PIROXICAM 20 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures PIROXICAM 20 MG CAPSULE?
PIROXICAM 20 MG CAPSULE (NDC 42571017701) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.